Kura Oncology, Inc. logo KURA - Kura Oncology, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 14
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $19.33 DETAILS
HIGH: $23.00
LOW: $15.00
MEDIAN: $20.00
CONSENSUS: $19.33
UPSIDE: 85.69%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue
Revenue 67.5 53.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.1 0 0.8 0 0 0.2 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Gross Profit 67.4 53.9 (0.8) 0 0 (0.2) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0
Operating Expenses
R&D Expenses 251.1 170.0 115.2 92.8 84.7 60.4 47.8 46.8 26.4 20.4 17.8 8.0 0 0 0 0 0 0
SG&A Expenses 120.0 77.1 50.6 47.1 46.5 31.3 19.7 16.1 9.7 8.0 6.1 3.8 0.0 0.0 0.0 0.0 0.0 0
Other Expenses 0 0 (0.8) 0 0 0 0 0 0 0 0 2.0 0 0 0 0 0 (0.0)
Operating Expenses 371.1 247.1 165.0 139.9 131.3 91.7 67.5 62.9 36.1 28.4 23.9 10.9 0.0 0.0 0.0 0.0 0.0 (0.0)
Operating Income
Operating Income (303.6) (193.2) (165.8) (139.9) (131.3) (91.9) (67.5) (62.9) (36.1) (28.4) (23.9) (11.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Interest Expense 1.5 1.6 1.5 0.2 0.4 0.6 0.6 1.0 0.9 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0
Interest Income 26.8 22.8 14.7 4.3 1.2 2.8 4.7 3.2 0.8 0.5 0.1 0 0 0 0 0 0 0
Profitability
EBITDA (275.8) (169.5) (150.2) (134.9) (129.5) (88.9) (67.5) (62.9) (36.0) (28.3) (23.8) (11.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
EBIT (276.9) (170.3) (151.1) (135.6) (130.1) (89.0) (67.5) (62.9) (36.1) (28.4) (23.9) (11.8) (0.0) (0.0) (0.0) (0.0) (0.0) 0
Income Before Tax (278.4) (172.0) (152.6) (135.8) (130.5) (89.6) (63.1) (60.4) (35.4) (27.6) (22.6) (11.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Income Tax Expense 0.3 2.0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 0
Net Income (278.7) (174.0) (152.6) (135.8) (130.5) (89.6) (63.1) (60.4) (35.4) (27.6) (22.6) (11.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Per Share Data
EPS (Basic) -3.18 -2.02 -2.08 -2.03 -1.97 -1.69 -1.51 -1.72 -1.52 -1.47 -2.28 -2.69 -0.01 -0.01 -0.00 -0.00 -0.00 -0.01
EPS (Diluted) -3.18 -2.02 -2.08 -2.03 -1.97 -1.69 -1.51 -1.72 -1.52 -1.47 -2.28 -2.69 -0.01 -0.01 -0.00 -0.00 -0.00 -0.01
Shares Outstanding 87.7 86.2 73.2 67.0 66.4 53.1 41.9 35.2 23.2 18.7 9.9 4.1 5 5 5 5 5 5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 149.1 224.5 37.3 51.8 90.7 325.5 26.1 16.1 11.4 9.7 0.0 0.0
Short-Term Investments 518.1 502.9 386.6 386.2 427.3 307.8 210.8 162.9 81.7 58.1 0 0
Net Receivables 12.6 0 0 0 0 0 0.0 0.2 0.2 0.3 0 0
Inventory 0.4 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 28.4 17.4 8.5 8.4 0 0 (0.0) 2.0 1.3 0.7 0 0
Total Current Assets 708.7 744.8 432.5 446.4 522.3 637.3 239.6 181.2 94.6 68.8 0.0 0.0
Non-Current Assets
Property, Plant & Equipment 15.2 7.5 8.9 6.4 8.2 8.4 0.3 0 0.0 0.0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 14.5 7.8 7.6 3.5 3.5 1.6 2.1 1.2 1.2 1.0 0 0
Total Non-Current Assets 29.7 15.3 16.5 9.9 11.8 9.9 2.4 1.2 1.2 1.0 0 0
Total Assets 738.4 760.2 448.9 456.3 534.1 647.2 242.0 182.4 95.9 69.8 0.0 0.0
Current Liabilities
Account Payables 5.0 1.5 2.3 1.5 3.2 2.8 3.5 3.9 1.2 0.6 0 0
Short-Term Debt 1.3 2.6 0 0 0 3 0.2 0 1.5 0 0.0 0
Deferred Revenue 0 24.3 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 110.4 17.5 13.2 10.3 7.9 7.0 3.7 (0.2) 0 0 0 0
Total Current Liabilities 117.0 78.7 35.3 24.1 22.5 26.0 15.6 13.6 10.0 5.5 0.0 0
Non-Current Liabilities
Long-Term Debt 9.7 6.9 9.3 9.2 0 4.2 7.2 7.5 5.6 7.3 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3.2 1.8 0.7 0.3 0.4 0.4 0.4 0.3 0.4 0.2 0.0 0
Total Non-Current Liabilities 447.3 267.8 16.4 12.0 5.0 10.3 7.6 7.8 6.0 7.5 0.0 0
Total Liabilities 564.2 346.5 51.7 36.0 27.4 36.3 23.2 21.4 16.0 12.9 0.0 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (1,174.1) (895.4) (721.4) (568.8) (433.0) (302.5) (212.9) (149.7) (89.3) (53.9) (0.1) (0.0)
Accumulated Other Comprehensive Income 1.0 0.8 (1.3) (8.0) (1.8) 0.0 0.3 (0.1) (0.0) (0.0) 0 0
Total Stockholders' Equity 174.1 413.6 397.3 420.3 506.6 610.9 218.8 161.0 79.9 56.9 (0.0) 0.0
Total Liabilities & Equity 738.4 760.2 448.9 456.3 534.1 647.2 242.0 182.4 95.9 69.8 0.0 0.0
Debt Metrics
Total Debt 20.5 16.6 17.2 14.0 6.9 15.0 7.8 7.5 7.1 7.3 0.0 0
Net Debt (128.6) (207.9) (20.1) (37.8) (83.8) (310.5) (18.4) (8.6) (4.3) (2.4) 0.0 (0.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (278.7) (174.0) (152.6) (135.8) (130.5) (89.6) (63.1) (60.4) (35.4) (27.6)
Depreciation & Amortization (7.5) 0.8 0.8 0.8 0.6 0.2 0 0.0 0.0 0.0
Stock-Based Compensation 37.1 33.9 28.1 26.3 23.6 12.8 9.4 8.7 4.5 2.1
Change in Working Capital 184.4 286.2 7.8 (3.0) (3.2) 6.4 0.1 4.4 2.6 (0.1)
Other Non-Cash Items 0.5 (12.6) (8.9) 1.7 0.4 0.4 (1.1) 0.2 0.1 0.0
Operating Cash Flow (64.1) 134.3 (124.8) (110.1) (104.6) (69.8) (54.8) (48.7) (28.4) (25.3)
Investing Activities
Capital Expenditure (6.6) (0.5) (0.2) (0.6) (1.1) (2.2) 0 0 0 0
Acquisitions 0 0 0 (0.0) 0.1 0.1 0 0 0 0
Purchases of Investments (761.6) (659.0) (409.8) (270.7) (445.7) (321.0) (227.6) (237.4) (100.6) (56.4)
Sales/Maturities of Investments 755.1 557.9 425.5 303.9 320.0 223.2 181.2 158.1 77.2 68.6
Other Investing Activities 0 0 0 0.0 (0.1) (0.1) 0 (0.1) (0.0) 0.0
Investing Cash Flow (13.1) (101.6) 15.6 32.6 (126.8) (99.9) (46.3) (79.3) (23.4) 12.2
Financing Activities
Net Debt Issuance 0 0 0 10 (7.2) (0.2) 0 (0.6) 0 7.5
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 8.6 1.2 3.8 (0.6) 10.2 2.9 1.1 53.6 0
Financing Cash Flow 1.8 154.4 94.8 38.6 (3.4) 469.3 111.1 132.6 53.6 7.5
Cash Position
Net Change in Cash (75.4) 187.1 (14.5) (38.9) (234.8) 299.6 10.0 4.7 1.7 (5.7)
Cash at Beginning 224.5 37.3 51.8 90.9 325.7 26.1 16.1 11.4 9.7 15.4
Cash at End 149.1 224.5 37.3 52.0 90.9 325.7 26.1 16.1 11.4 9.7
Free Cash Flow (70.7) 133.8 (125.0) (110.7) (105.7) (72.0) (54.8) (48.7) (28.4) (25.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Income Statement
Revenue 67.5 53.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 67.4 53.9 (0.8) 0 0 (0.2) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0
Operating Income (303.6) (193.2) (165.8) (139.9) (131.3) (91.9) (67.5) (62.9) (36.1) (28.4) (23.9) (11.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Net Income (278.7) (174.0) (152.6) (135.8) (130.5) (89.6) (63.1) (60.4) (35.4) (27.6) (22.6) (11.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
EPS (Diluted) -3.18 -2.02 -2.08 -2.03 -1.97 -1.69 -1.51 -1.72 -1.52 -1.47 -2.28 -2.69 -0.01 -0.01 -0.00 -0.00 -0.00 -0.01
Balance Sheet
Cash & Equivalents 149.1 224.5 37.3 51.8 90.7 325.5 26.1 16.1 11.4 9.7 0.0 0.0
Total Assets 738.4 760.2 448.9 456.3 534.1 647.2 242.0 182.4 95.9 69.8 0.0 0.0
Total Debt 20.5 16.6 17.2 14.0 6.9 15.0 7.8 7.5 7.1 7.3 0.0 0
Stockholders' Equity 174.1 413.6 397.3 420.3 506.6 610.9 218.8 161.0 79.9 56.9 (0.0) 0.0
Cash Flow
Operating Cash Flow (64.1) 134.3 (124.8) (110.1) (104.6) (69.8) (54.8) (48.7) (28.4) (25.3)
Capital Expenditure (6.6) (0.5) (0.2) (0.6) (1.1) (2.2) 0 0 0 0
Free Cash Flow (70.7) 133.8 (125.0) (110.7) (105.7) (72.0) (54.8) (48.7) (28.4) (25.3)